{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T23:35:21Z","timestamp":1778110521099,"version":"3.51.4"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100019567","name":"Chiba Foundation for Health Promotion and Disease Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019567","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020447","name":"Japanese Association of Cardiovascular Intervention and Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020447","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.ahj.2023.01.009","type":"journal-article","created":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T05:24:50Z","timestamp":1673587490000},"page":"69-76","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Characteristics and outcomes of patients with no standard modifiable risk factors undergoing primary revascularization for acute myocardial infarction: Insights from the nationwide Japanese percutaneous coronary intervention registry"],"prefix":"10.1016","volume":"258","author":[{"given":"Yuichi","family":"Saito","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taku","family":"Inohara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shun","family":"Kohsaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Wada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Itaru","family":"Takamisawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyohei","family":"Yamaji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Amano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshio","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Kozuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2023.01.009_bib0001","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.ahj.2006.12.018","article-title":"Documented traditional cardiovascular risk factors and mortality in non-ST-segment elevation myocardial infarction","volume":"153","author":"Roe","year":"2007","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2023.01.009_bib0002","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1177\/2047487312460514","article-title":"Risk factors for coronary heart disease and survival after myocardial infarction","volume":"21","author":"Nauta","year":"2014","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.ahj.2023.01.009_bib0003","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1177\/2047487317720287","article-title":"Increasing proportion of ST elevation myocardial infarction patients with coronary atherosclerosis poorly explained by standard modifiable risk factors","volume":"24","author":"Vernon","year":"2017","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.ahj.2023.01.009_bib0004","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jacc.2017.11.007","article-title":"Cardiovascular risk and statin eligibility of young adults after an MI: partners YOUNG-MI registry","volume":"71","author":"Singh","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2023.01.009_bib0005","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.013296","article-title":"ST-segment-elevation myocardial infarction (STEMI) patients without standard modifiable cardiovascular risk factors-how common are they, and what are their outcomes?","volume":"8","author":"Vernon","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ahj.2023.01.009_bib0006","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(21)00272-5","article-title":"Mortality in STEMI patients without standard modifiable risk factors: a sex-disaggregated analysis of SWEDEHEART registry data","volume":"397","author":"Figtree","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2023.01.009_bib0007","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.amjcard.2021.10.032","article-title":"Coronary artery disease without standard cardiovascular risk factors","volume":"164","author":"Yamamoto","year":"2022","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2023.01.009_bib0008","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.jcin.2022.03.036","article-title":"Clinical outcomes in patients with ST-segment elevation MI and no standard modifiable cardiovascular risk factors","volume":"15","author":"Figtree","year":"2022","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2023.01.009_bib0009","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.876465","article-title":"Comparison of mortality outcomes in patients with acute myocardial infarction with or without standard modifiable cardiovascular risk factors","volume":"9","author":"Sia","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.ahj.2023.01.009_bib0010","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1093\/eurjpc\/zwab200","article-title":"Addressing disparities of care in non-ST-segment elevation myocardial infarction patients without standard modifiable risk factors: insights from a nationwide cohort study","volume":"29","author":"Moledina","year":"2022","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.ahj.2023.01.009_bib0011","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.hlc.2022.06.666","article-title":"Clinical characteristics and prognosis of patients with no standard modifiable risk factors in acute myocardial infarction","volume":"31","author":"Suzuki","year":"2022","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.ahj.2023.01.009_bib0012","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.024818","article-title":"Mortality and cardiovascular outcomes in patients presenting with non-ST elevation myocardial infarction despite no standard modifiable risk factors: results from the SWEDEHEART registry","volume":"11","author":"Figtree","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ahj.2023.01.009_bib0013","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.1093\/eurheartj\/ehx515","article-title":"Improved outcomes in patients with ST-elevation myocardial infarction during the last 20\u2009years are related to implementation of evidence-based treatments: experiences from the SWEDEHEART registry 1995-2014","volume":"38","author":"Szummer","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2023.01.009_bib0014","doi-asserted-by":"crossref","first-page":"3766","DOI":"10.1093\/eurheartj\/ehy554","article-title":"Relations between implementation of new treatments and improved outcomes in patients with non-ST-elevation myocardial infarction during the last 20 years: experiences from SWEDEHEART registry 1995 to 2014","volume":"39","author":"Szummer","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2023.01.009_bib0015","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/S0140-6736(11)60274-2","article-title":"Fifty years of pursuing a healthy society in Japan","volume":"378","author":"Reich","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2023.01.009_bib0016","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(11)61148-3","article-title":"Human security and universal health insurance","volume":"379","author":"Anand","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2023.01.009_bib0017","doi-asserted-by":"crossref","first-page":"3822","DOI":"10.1093\/eurheartj\/ehab474","article-title":"Coronary artery disease in the absence of traditional risk factors: a call for action","volume":"42","author":"Avis","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2023.01.009_bib0018","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s12928-021-00832-0","article-title":"Japanese nationwide PCI (J-PCI) registry annual report 2019: patient demographics and in-hospital outcomes","volume":"37","author":"Ando","year":"2022","journal-title":"Cardiovasc Interv Ther"},{"key":"10.1016\/j.ahj.2023.01.009_bib0019","article-title":"Percutaneous coronary intervention during the COVID-19 pandemic in Japan: insights from nationwide registration data","volume":"22","author":"Yamaji","year":"2022","journal-title":"Lancet Reg Health West Pac"},{"key":"10.1016\/j.ahj.2023.01.009_bib0020","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/j.jacc.2020.07.037","article-title":"Comparative trends in percutaneous coronary intervention in Japan and the United States, 2013 to 2017","volume":"76","author":"Inohara","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2023.01.009_bib0021","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s12928-020-00752-5","article-title":"Temporal trends in coronary intervention strategies and their impact on one-year clinical events: data from a Japanese multicenter real-world cohort study","volume":"37","author":"Sakamoto","year":"2022","journal-title":"Cardiovasc Interv Ther"},{"key":"10.1016\/j.ahj.2023.01.009_bib0022","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s12928-020-00649-3","article-title":"Imaging-guided PCI for event suppression in Japanese patients with acute coronary syndrome: a community-based observational cohort registry","volume":"36","author":"Yamashita","year":"2021","journal-title":"Cardiovasc Interv Ther"},{"key":"10.1016\/j.ahj.2023.01.009_bib0023","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s12928-021-00824-0","article-title":"Clinical expert consensus document on intravascular ultrasound from the Japanese Association of Cardiovascular Intervention and Therapeutics","volume":"37","author":"Saito","year":"2022","journal-title":"Cardiovasc Interv Ther"},{"key":"10.1016\/j.ahj.2023.01.009_bib0024","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s12928-022-00845-3","article-title":"Expert consensus statement for quantitative measurement and morphological assessment of optical coherence tomography: update 2022","volume":"37","author":"Fujii","year":"2022","journal-title":"Cardiovasc Interv Ther"},{"key":"10.1016\/j.ahj.2023.01.009_bib0025","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s12928-020-00731-w","article-title":"Contemporary coronary drug-eluting and coated stents: a mini-review","volume":"36","author":"Saito","year":"2021","journal-title":"Cardiovasc Interv Ther"},{"key":"10.1016\/j.ahj.2023.01.009_bib0026","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s12928-020-00669-z","article-title":"Contemporary use and trends in percutaneous coronary intervention in Japan: an outline of the J-PCI registry","volume":"35","author":"Sawano","year":"2020","journal-title":"Cardiovasc Interv Ther"},{"key":"10.1016\/j.ahj.2023.01.009_bib0027","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.jcin.2017.02.015","article-title":"Impact of institutional and operator volume on short-term outcomes of percutaneous coronary intervention: a report from the Japanese nationwide registry","volume":"10","author":"Inohara","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2023.01.009_bib0028","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1161\/CIRCULATIONAHA.117.029289","article-title":"Standardized endpoint definitions for coronary intervention trials: the Academic Research Consortium-2 Consensus Document","volume":"137","author":"Garcia-Garcia","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2023.01.009_bib0029","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","article-title":"Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (INTERHEART study): a case-control study","volume":"364","author":"Yusuf","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2023.01.009_bib0030","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.amjcard.2007.03.035","article-title":"Comparison of baseline characteristics, treatment patterns, and in-hospital outcomes of Asian versus non-Asian white Americans with non-ST-segment elevation acute coronary syndromes from the CRUSADE Quality Improvement Initiative","volume":"100","author":"Wang","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2023.01.009_bib0031","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/s41586-020-2263-3","article-title":"Identification of type 2 diabetes loci in 433,540 East Asian individuals","volume":"582","author":"Spracklen","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ahj.2023.01.009_bib0032","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1093\/eurheartj\/ehu286","article-title":"Association between clinical presentations before myocardial infarction and coronary mortality: a prospective population-based study using linked electronic records","volume":"35","author":"Herrett","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2023.01.009_bib0033","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1093\/eurheartj\/ehz372","article-title":"Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk","volume":"40","author":"Urban","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2023.01.009_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2020.100116","article-title":"Progression of coronary atherosclerosis in patients without standard modifiable risk factors","volume":"4","author":"Mazhar","year":"2020","journal-title":"Am J Prev Cardiol"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870323000170?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870323000170?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:09:44Z","timestamp":1757570984000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870323000170"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":34,"alternative-id":["S0002870323000170"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2023.01.009","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characteristics and outcomes of patients with no standard modifiable risk factors undergoing primary revascularization for acute myocardial infarction: Insights from the nationwide Japanese percutaneous coronary intervention registry","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2023.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}